Achillea millefolium Aqueous Extract does not Impair Recognition Memory in Mice by Ayoobi, F et al.
Ayoobi et al 
Trop J Pharm Res, April 2013;12 (2): 
 
209 
Tropical Journal of Pharmaceutical Research April 2013; 12 (2): 209-213 
ISSN: 1596-5996 (print); 1596-9827 (electronic) 
© Pharmacotherapy Group, Faculty of Pharmacy, University of Benin, Benin City, 300001 Nigeria.  
All rights reserved. 
 
Available online at http://www.tjpr.org 
http://dx.doi.org/10.4314/tjpr.v12i2.12 
Original Research Article 
 
 
Achillea millefolium Aqueous Extract does not Impair 
Recognition Memory in Mice 
 
Fatemeh Ayoobi, Ali Roohbakhsh, Mohammad Allahtavakoli, Reza Vazirinejad, 
Soodeh Rajabi and Ali Shamsizadeh* 
Physiology-Pharmacology Research Center, Rafsanjan University of Medical Sciences, Rafsanjan, Iran 
 
*For correspondence: E-mail: ashamsi@rums.ac.ir, alishamsy@gmail.com; Tel: +983915234003; Fax: +983915225209 
 
 
Received:  17 July 2012        Revised accepted: 30 January 2013 
 
Abstract 
Purpose: To investigate the effect of the aqueous extract of Achillea millefolium on recognition memory 
in mice. 
Methods:  Male mice (35) were used. The aqueous extract of A. millefolium was prepared using a 
Soxhlet apparatus and injected intraperitoneally in a dose of 50, 250, 500 or 1000 mg/kg daily for 20 
days. The control group was treated with saline 1 ml/mouse/day. Tactile learning was assessed using 
the novel object recognition test (NORT) in a dark room which entailed measurement of the distance 
travelled during trial and test phases.  
Results: Treatment with different doses of A. millefolium did not affect activity levels (based on the 
distance travelled during trial and test phases). The total time and frequency of visits to the sample 
objects in trial and test phases were not statistically significant between control and A. millefolium 
treated groups (p >  0.05). A comparison of the discrimination ratio between the experimental groups 
revealed no difference. Administration of A. millefolium extract for 20 days did not decrease body weight 
or cause death in the treated animals.  
Conclusion: The result of this study demonstrates that chronic treatment with different doses of the 
aqueous extract of A. millefolium did not impair recognition memory in mice. 
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Achillea millefolium (Asteraceae), known as 
yarrow (“mil folhas”), is one of the most 
widespread and frequently used medicinal plants 
worldwide [1].  
 
A. millefolium has been used as a treatment for 
wound healing, infectious diseases, pain and 
gastrointestinal complaints as well as many other 
conditions [2]. Although A. millefolium has been 
suggested as a folk remedy for the traditional 
treatment of central nervous system diseases, 
few data have been published supporting this 
claimed ethnomedical action. Elmann et al 
reported that A. millefolium extract has anti-
inflammatory effects on lipopolysaccharide 
(LPS)-activated primary cultures of brain 
microglial cells. Therefore, they concluded that A. 
millefolium could be beneficial in preventing/ 
treating neurodegenerative diseases like 
Alzheimer and Parkinson [3]. In another study, 
Molina- Hernandez et al reported anticonflict-like 
actions of aqueous extract of the flowers of A. 
millefolium in rats [4]. Also recently, Baretta et al 
reported that acute and chronic oral 
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administration of the hydroalcoholic extract of A. 
millefolium exerted anxiolytic-like effects in mice 
[5].  
 
The objective of the present study was to 
investigate the effects of chronic treatment with 
the aqueous extract of A. millefolium on learning 
and memory. To address this question, we 
investigated the effect of different doses of 
aqueous extract of A. millefolium on tactile 
learning (measured by novel object recognition 






We used 35 NMARI male mice (weighing 24 - 34 
g). The animal ages were 8-10 week. The 
animals were purchased from Rafsanjan 
University of Medical Sciences and maintained 
on a 12 h light/dark cycle (light on: 07:00 to 19:00 
h) with free access to food and water. The animal 
house temperature was maintained at 23 ± 2.0 
°C. Procedures involving animals and their care 
were conducted in accordance with the Guide to 
the Care and Use of Experimental Animals [6]. 
Approval from the institutional animal ethics 
committee was also obtained (ref no; 1057). 
During the experiments, all the animals were 
weighed every day. 
 
Plant material  
 
The plant material was collected in March 2011 
from Isfahan Botany Herbarium. and was 
identified by Dr. Valiollah Mozaffarian at Botany 
Research Division, Research Institute of Forests 
and Rangelands, Tehran-Iran. A voucher 
specimen has been kept in Isfahan Botany 
Herbarium voucher specimen no. 9757. The 
dried aerial parts of the plant (200 g) were rinsed 
with distilled water, dried, ground into powder 
and extracted in a Soxhlet apparatus with 
distilled water. The solvent was evaporated 
under reduced pressure at 40 °C. The extract 
was reconstituted by dissolving it in distilled 
water before use. 
 
Animal groups  
 
The mice were randomly allocated into 5 groups 
with seven mice in each group as follows: 
Control, and four treatment groups in which the 
mice were treated with 50, 250, 500 or 1000 
mg/kg A. millefolium aqueous extract, 
respectively, daily for 20 days. The drug was 
administered intraperitoneally. 
Object recognition task 
 
The object recognition task assesses recognition 
memory and is based on a natural tendency of 
animals to preferentially explore novel objects, as 
opposed to familiar objects [7]. The apparatus 
was a Plexiglas box (35 × 35 × 35 cm) with a 
black plastic floor placed in a dimly illuminated 
room [8]. The objects to be discriminated were 
square and triangular iron blocks. The behavior 
of mice was recorded by a camera positioned 
directly above the box and the data subsequently 
analysed using Ethovison software (Noldus, 
Wageningen, Netherlands). 
 
The object recognition task was done in 3 
phases (habituation, training and test phases) 
with 24 h interval between habituation and 
training phases and 4 h interval between training 
and test phases. During the habituation phase, 
the mice were allowed to freely explore the box 
in the absence of objects for 30 min. In the 
training phase (T1), each mouse was placed in 
the box with one object and allowed to explore 
for 10 min. To prevent side preference affecting 
the results, the position and shape of the object 
were changed after each animal was tested. All 
mice were placed in the box at the same point 
and they were facing the same direction. In the 
test phase (T2), each mouse was returned to the 
box where it was presented with a familiar object 
from the training trial (the position of this object 
was consistent between both training and test 
phases) and a novel object. Exploration time in 
T2 was 10 min similar to T1. Care was taken to 
avoid olfactory stimuli by cleaning the box and 
objects with 70% ethanol between tests [9]. The 
time spent (in seconds) for exploring the objects 
was recorded. Exploration was defined as 
pointing the nose to the object at a distance ≤ 2 
cm. Climbing or sitting on an object was not 
considered as exploration. In T2 phase, a 
discrimination ratio was calculated using the 
following formula: [total time spent in exploring 
both objects divided by the time spent exploring 
novel objects only] × 100. Mice showing a total 
exploration time < 10 s in either training or 




The statistical analysis was performed using 
Excel and SPSS software. All data are 
expressed as mean ± SEM. Differences between 
the groups were determined using ANOVA 
followed by Tukey post hoc test. Paired t-test 
was also used to compare activity level between 
trial and test phases and also to compare weight 
changes in each group. A p-values < 0.05 was 
considered statistically significant. 
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The body weight of animals in all the groups 
(both control and treatment) increased (p < 0.05) 
during the 20-day administration of A. millefolium 
extract (Figure 1). We did not observe any 
mortality in animals during the treatment period. 
 
 
Figure 1: Weight changes in control and A. millefolium 
aqueous extract-treated animals over a 20-day period. 
Data are expressed as mean ± SEM (n = 7)  
 




Activity level was assessed by measuring the 
distance travelled during trial (T1) and test (T2) 
phases (Figure 2). In control group, the distance 
travelled in T1 and T2 were not significantly 
different (p = 0.6). In animals that received 50, 
250, 500 and 1000 mg/kg  extract, the distance 
travelled in T1 and T2 were not significantly 
different (p > 0.05).  
 
In extract-treated groups, the distance travelled 
in T1 and T2 did not differ significantly compared 




Figure 2: Activity level of control and A. millefolium 
aqueous extract-treated animals. Activity levels 
measured by distance travelled in 10 min in both T1 
and T2 phases. Data are expressed as mean ± SEM 
(n = 7) 
 
Object recognition task: Trial phase (T1) 
 
The total time spent exploring one object in T1 
(Table 1) was not statistically significant between 
control and extract-treated groups (p = 0.5). 
Similarly, no reliable differences were found for 
the frequency of visits to the sample objects 
between experimental groups (Table 1, p = 
0.09). 
 
Object recognition task: Test phase (T2) 
 
Object exploration times during the test phase 
(T2) in experimental groups are also shown in 
Table 1. No significant differences were found for 
the time to explore novel (p = 0.1) and familiar (p 
= 0.9) objects between experimental groups. The 
mean of total exploration time of both objects 
(familiar + novel) were not statistically significant 
between control and extract-treated groups (p = 
0.75). Moreover, no significant reliable 
differences were found for the frequency of visits 
to the novel(p = 0.6) and familiar (p = 0.6) objects 
between experimental groups (Table 1). A 
comparison of the discrimination ratio (Figure 3) 
between the experimental groups revealed no 
difference (p = 0.3). 
 
 
Figure 3: Discrimination ratio for control and A. 
millefolium aqueous extract-treated animals. Data are 




The growing number of studies on the possible 
beneficial effect of A. millefolium extract for 
prevention or treatment of neurodegenerative 
diseases may be attributed to the plant’s 
potentials. However, this raises important 
questions about possible side effects of the plant 
on the nervous system function, especially on 
learning and memory. Therefore, in this study, 
we sought to investigate the effect of A. 
millefolium aqueous extract on tactile learning 
using the novel object recognition task. Our 
results demonstrated that long-term treatment 
with different doses (50, 250, 500 and 1000  
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Table 1: Frequencies and times of visits novel or familiar objects in T1 and T2 among extract and control groups 
 











Total exploration  
time (sec) 
 





visits to both 
objects 
82.4±15.1 77.8±15 50.5±22.8 49.1±12.3 122.5±25.8 
Time to visit 
familiar object 65.3±28.9 68.9±4.7 52.9±18.4 43.2±10.8 59.8±9.8 
 













































visits to novel 
object 
147.7±56.3 101.4±11.6 63.5±18.1 92.4±21.6 66.2±11.6 
 
Data are expressed as mean ± SEM; T2 results were obtained 24 h after obtaining T1 results 
 
mg/kg) of the aqueous extract of A. millefolium 
did not impair this ability in mice.  
 
Most neurodegenerative diseases such as 
Alzheimer, Parkinson, lateral sclerosis and 
multiple sclerosis have deleterious effect on 
learning and memory [10] and these diseases 
mainly destroy integrative and cognitive abilities 
[10]. 
  
A. millefolium is one of the oldest known 
botanicals used by humans. Chandler et al 
compiled a list of 30 medicinal uses A. 
millefolium. They divided its uses into four 
categories including wounds and skin damage, 
bleeding conditions, digestive problems and 
general tonic use [12]. Human use of A. 
millefolium is mainly in the form of the aqueous 
extract. In several studies, various doses of A. 
mellifolium extracts ranging from 8 to 3000 mg/kg 
were used. However, the most frequent doses for 
A. millefolium extracts were between 50 to 1000 
mg/kg [2].  
 
Most of previous studies reported no sign of 
toxicity for A. millefolium. Acute treatment of rats 
with  A. millefolium aqueous extract up to 10 g/kg 
orally and up to 3 g/kg intraperitoneally caused 
no death [13]. In addition, long-term studies 
demonstrated little side effects or toxicities in 
animals treated with A. millefolium extract [13]. In 
a study on the pregnant female rats, animals 
treated with the ethanol extracts of A. millefolium 
at a dose of 2.8 g/kg/day for one week, no signs 
of maternal toxicity were reported [14]. 
  
However, there are some reports about toxicity 
and side effects of A. millefolium. One side effect 
of A. millefolium is allergic contact dermatitis. It 
has been reported that the concentration of 
sensitizing compounds (guaianolides) of A. 
millefolium diminish in dried or processed 
material due to degradation [15]. Graf et al 
reported that yarrow tea might have weak 
genotoxic effect in drosophila [16]. In male 
rodents, it is reported that high doses of both 
ethanol [17] and aqueous extracts [18] of A. 
millefolium have some deleterious effects on 
spermatogenesis. However, our results 
demonstrated that the aqueous extract of A. 
millefolium has no deleterious effect on 
recognition memory.  
 
In addition, the anxiolytic-like properties of A. 
millefolium was recently reported by Baretta et al 
[5]. On the other hand, it has been reported that 
benzodiazepines as standard anxiolytics induce 
anterograde amnesia [19]. Therefore, it may be 
suggested that aqueous extract of A. millefolium 
may reduce anxiety with little side effects on 
memory.    
 
On the other hand, there are reports about 
biological effects of other forms of Achillea 
extracts. For example, it is reported that a 
methanol extract of Achillea is active against 
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helicobacter pylori [20]. A lipophilic fraction from 
A. millefolium reduced pain responses in an 
acetic acid-induced writhing test. Therefore, we 
suggest that in future studies other forms of A. 
millefolium extracts be tested for their possible 




As there might be some new implications for A. 
millefolium in preventing or treating mental 
disorders [2], the result of present study 
demonstrated that long term treatment with 
aqueous extract of A. millefolium has no 
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